<DOC>
	<DOCNO>NCT01225549</DOCNO>
	<brief_summary>The purpose study evaluate efficacy AZD5423 patient mild asthma challenge inhaled allergen .</brief_summary>
	<brief_title>The Study Will Evaluate Efficacy AZD5423 Patients With Mild Asthma Challenged With Inhaled Allergen</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>1860 year age Prebronchodilatory FEV1 ≥70 % predict normal allergic asthmatic history episodic wheeze Positive allergen induce early late airway bronchoconstriction show ≥ 20 % fall FEV1 early ≥ 15 % late response Positive skin prick test common aeroallergens Any clinically significant disease disorder Any clinically relevant abnormal find screen examination Smoker exsmoker stop smoke &lt; 12 month prior study start Worsening asthma respiratory infection within 6 week visit 1 Allergenspecific immunotherapy within 6 month prior visit 1</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Allergen Challenge</keyword>
	<keyword>Asthma</keyword>
	<keyword>Inhaled selective glucocorticoid receptor agonist ( iSEGRA )</keyword>
</DOC>